Restored perfusion and reduced inflammation in the infarcted heart after grafting stem cells with a hyaluronan-based scaffold

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 4, 2013, Pages 518-530

  Muscari, Claudio ^a,c   Bonafè, Francesca ^a,c   Martin Suarez, Sofia ^a   Valgimigli, Simond ^a   Valente, Sabrina ^a   Fiumana, Emanuela ^a,c   Fiorelli, Federico ^a   Rubini, Giuseppe ^b   Guarnieri, Carlo ^a,c   Caldarera, Claudio Marcello ^a,c   Capitani, Ombretta ^a   Arpesella, Giorgio ^a,c   Pasquinelli, Gianandrea ^a,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ultravet Diagnostic   (Italy)

^c National Institute for Cardiovascular Research INRC   (Italy)

Author keywords

Heart perfusion; Hyaluronan based scaffold; Mesenchymal stem cell; Myocardial infarction; Tissue engineering; Woven fabric

Indexed keywords

HYALURONIC ACID; TISSUE SCAFFOLD;

ANGIOGENESIS; ANIMAL; ARTICLE; AUTOTRANSPLANTATION; CELL ADHESION; CELL CULTURE; CELL SHAPE; CELL SURVIVAL; CHEMISTRY; CORONARY BLOOD VESSEL; EXTRACELLULAR MATRIX; FEMALE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTHESES AND ORTHOSES; SWINE;

ANIMALS; CELL ADHESION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; CORONARY VESSELS; EXTRACELLULAR MATRIX; FEMALE; HYALURONIC ACID; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PROSTHESES AND IMPLANTS; SUS SCROFA; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS;

ANIMALIA; SUIDAE;

EID: 84877044388     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12039     Document Type: Article

References (34)

1. Mingliang R, Bo Z, Zhengguo W. Stem cells for cardiac repair: status, mechanisms, and new strategies. Stem Cells Int. 2011; 2011: 1-8.
2. Wu J, Li J, Zhang N, et al. Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation. Basic Res Cardiol. 2011; 106: 317-24.
3. Nesselmann C, Ma N, Bieback K, et al. Mesenchymal stem cells and cardiac repair. J Cell Mol Med. 2008; 12: 1795-810.
4. van den Borne SW, Diez J, Blankesteijn WM, et al. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol. 2010; 7: 30-7.
5. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990; 81: 1161-72.
6. Haider HK, Akbar SA, Ashraf M. Angiomyogenesis for myocardial repair. Antioxid Redox Signal. 2009; 11: 1929-44.
7. Tse HF, Lau CP. Therapeutic angiogenesis with bone marrow-derived stem cells. J Cardiovasc Pharmacol Ther. 2007; 12: 89-97.
8. Tse HF, Yiu KH, Lau CP. Bone marrow stem cell therapy for myocardial angiogenesis. Curr Vasc Pharmacol. 2007; 5: 103-12.
9. Doyle B, Caplice NM. Targeting angiogenesis versus myogenesis with cardiac cell therapy. Expert Rev Cardiovasc Ther. 2006; 4: 745-53.
10. Kocher AA, Schuster MJ, Szabolcs S, et al. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001; 7: 430-6.
11. Wen Z, Zheng S, Zhou C, et al. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med. 2011; 15: 1032-43.
12. Smits AM, van Vliet P, Hassink RJ, et al. The role of stem cells in cardiac regeneration. J Cell Mol Med. 2005; 9: 25-36.
13. Wang H, Zhou J, Liu Z, et al. Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med. 2010; 14: 1044-55.
14. Pasquinelli G, Orrico C, Foroni L, et al. Mesenchymal stem cell interaction with a non-woven hyaluronan-based scaffold suitable for tissue repair. J Anat. 2008; 213: 520-30.
15. Pardue EL, Ibrahim S, Ramamurthi A. Role of hyaluronan angiogenesis and its utility to angiogenic tissue engineering. Organogenesis. 2008; 4: 203-14.
16. Benedetti L, Cortivo R, Berti T, et al. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomaterials. 1993; 14: 1154-60.
17. Boublik J, Park H, Radisic M, et al. Mechanical properties and remodeling of hybrid cardiac constructs made from heart cells, fibrin, and biodegradable, elastomeric knitted fabric. Tissue Eng. 2005; 11: 1122-32.
18. Campoccia D, Doherty P, Radice M, et al. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials. 1998; 19: 2101-27.
19. Binato R, de Souza Fernandez T, Lazzarotto-Silva C, et al. Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy. Cell Prolif. 2013; 46: 10-22.
20. Muscari C, Bonafé F, Stanic I, et al. Polyamine depletion reduces TNFalpha/MG132-induced apoptosis in bone marrow stromal cells. Stem Cells. 2005; 23: 983-91.
21. Muscari C, Gamberini C, Basile I, et al. Comparison between culture conditions improving growth and differentiation of blood and bone marrow cells committed to the endothelial cell lineage. Biol Proced Online. 2010; 12: 89-106.
22. Lisignoli G, Remiddi G, Cattini L, et al. An elevated number of differentiated osteoblast colonies can be obtained from rat bone marrow stromal cells using a gradient isolation procedure. Connect Tissue Res. 2001; 42: 49-58.
23. Pasquinelli G, Vinci MC, Gamberini C, et al. Architectural organization and functional features of early endothelial progenitor cells cultured in a hyaluronan-based polymer scaffold. Tissue Eng Part A. 2009; 15: 2751-62.
24. Broillet A, Puginier J, Ventrone R, et al. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent. Invest Radiol. 1998; 33: 209-15.
25. Schneider M. Design of an ultrasound contrast agent for myocardial perfusion. Echocardiography. 2000; 17: S11-6.
26. Agatia L, Tontib G, Pedrizzettic G, et al. Clinical application of quantitative analysis in real-time MCE. Euro J Echocard. 2004; 45: S9-15.
27. Liu J, Hu Q, Wang Z, et al. Autologous stem cell transplantation for myocardial repair. Am J Physiol Heart Circ Physiol. 2004; 287: H501-11.
28. Bosch P, Pratt SL, Stice SL. Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod. 2006; 74: 46-57.
29. Cui X, Xu H, Zhou S, et al. Evaluation of angiogenic activities of hyaluronan oligosaccharides of defined minimum size. Life Sci. 2009; 85: 573-7.
30. Slevin M, Krupinski J, Gaffney J, et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 2007; 26: 58-68.
31. Aguirre A, Planell JA, Engel E. Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. Biochem Biophys Res Commun. 2010; 400: 284-91.
32. Halkos ME, Zhao ZQ, Kerendi F, et al. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol. 2008; 103: 525-36.
33. Schuleri KH, Amado LC, Boyle AJ, et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol. 2008; 294: H2002-11.
34. Shi M, Liu ZW, Wang FS. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol. 2011; 164: 1-8.